Healthcare Infrastructure, Operations & Supply Chain

VB Spine Seeks Exclusive Rights to Augmedics Platform

Transaction will expand VB Spine’s enhanced visualization portfolio to include augmented reality navigation with the Augmedics xvision Spine System®

VB Spine LLC (“VB Spine”), the largest privately held spine company, today announced it has entered into a definitive agreement to acquire exclusive rights to the xvision Spine System® (xvision) from Augmedics, adding augmented reality (AR) navigation to VB Spine’s growing enhanced visualization portfolio. Augmedics is the first company to offer an FDA-cleared AR navigation platform in spine surgery, positioning VB Spine to become a world leader in AR-enabled spine solutions. The transaction is subject to approval and customary closing conditions and is expected to close in the coming weeks.

The xvision Spine System is designed to combine the benefits of navigation with the ease and utility of open surgery: visualization while looking directly at the patient, accuracy and precision, workflow efficiency, and radiation reduction. With nearly 13,000 patients treated with xvision, the transaction brings together two complementary portfolios focused on redefining spine care.

This transaction marks a foundational element in a broader enhanced visualization technology strategy for the company, building on the recent acquisition of the SpineHawk™ intraoperative spinal visualization platform from Robotron Surgical Technologies.

“We have long admired the xvision technology and potential of the platform,” said Marc Viscogliosi, co-CEO of VB Spine. “We believe with our implant integration and scale, we have the ability to harness the true potential of AR navigation. Combined with the SpineHawk platform, this will expand our existing spine solutions and supports our long-term roadmap to redefine spine care with differentiated technologies.”

“We are proud of the clinical impact xvision has made in spine surgery and VB Spine’s commitment to our world-class portfolio,” said Paul Ziegler, President and CEO of Augmedics. “This agreement will strengthen our competitive advantage as an augmented reality innovation engine as we turn our focus to expanding our reach into adjacent surgical indications.”

Subject to approval and closing, VB Spine and Augmedics intend to work together to support an orderly transition for customers.

Regulatory and Availability

The xvision Spine System® with xvision Spine System Software is FDA-cleared in the US. It is intended as an aid for precisely locating anatomical structures in either open, minimally invasive, or percutaneous spine procedures.

Forward-Looking Statements

Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law.

Related posts

Carrum Health Expands COE Network, Reaching 90% of Americans

PR Newswire

Auna Forms Strategic Collaboration with Sojitz to Boost Latin Healthcare

Business Wire

FluidAI Raises $2M from Canadian Government to Boost AI Care Tech

PR Newswire